Lipoprotein(a)—antisense therapy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1861-0714

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Lipoprotein(a)—antisense therapy ; volume:14 ; number:1 ; day:11 ; month:3 ; year:2019 ; pages:51-56 ; date:4.2019
Clinical research in cardiology supplements ; 14, Heft 1 (11.3.2019), 51-56, 4.2019

Creator: Vogt, Anja

Contributor: SpringerLink (Online service)

DOI: 10.1007/s11789-019-00096-2

URN: urn:nbn:de:101:1-2019051322203907925440

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:49 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Vogt, Anja
SpringerLink (Online service)

Other Objects (12)

Antisense and ribozyme methodology

Aufsatzsammlung

Antisense research and application

Antisense and ribozyme methodology

Hochschulschrift

Lipoprotein und apolipoprotein abnormalities in children undergoing maintenance hemodialysis therapy

Postmenopausal Hormone Replacement Therapy with Tibolone Decreases Serum Lipoprotein(a)

Hochschulschrift

Antisense oligonucleotide-based therapy against Fra-2, a novel target in liver fibrosis

Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne

$Lipoprotein subfractions$

Konferenzschrift | Kongress

Lipoprotein subfractions

Lipoprotein metabolism

Lipoprotein(a)

Lipoprotein (a)

Antisense and ribozyme methodology

Aufsatzsammlung

Antisense research and application

Antisense and ribozyme methodology

Hochschulschrift

Lipoprotein und apolipoprotein abnormalities in children undergoing maintenance hemodialysis therapy

Postmenopausal Hormone Replacement Therapy with Tibolone Decreases Serum Lipoprotein(a)

Hochschulschrift

Antisense oligonucleotide-based therapy against Fra-2, a novel target in liver fibrosis

Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne

$Lipoprotein subfractions$

Konferenzschrift | Kongress

Lipoprotein subfractions

Lipoprotein metabolism

Lipoprotein(a)

Lipoprotein (a)

Antisense and ribozyme methodology

Aufsatzsammlung

Antisense research and application

Antisense and ribozyme methodology

Hochschulschrift

Lipoprotein und apolipoprotein abnormalities in children undergoing maintenance hemodialysis therapy

Postmenopausal Hormone Replacement Therapy with Tibolone Decreases Serum Lipoprotein(a)

Hochschulschrift

Antisense oligonucleotide-based therapy against Fra-2, a novel target in liver fibrosis

Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne

$Lipoprotein subfractions$

Konferenzschrift | Kongress

Lipoprotein subfractions

Lipoprotein metabolism

Lipoprotein(a)

Lipoprotein (a)

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Lipoprotein(a)—antisense therapy

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Antisense and ribozyme methodology

Antisense research and application

Antisense and ribozyme methodology

Lipoprotein und apolipoprotein abnormalities in children undergoing maintenance hemodialysis therapy

Postmenopausal Hormone Replacement Therapy with Tibolone Decreases Serum Lipoprotein(a)

Antisense oligonucleotide-based therapy against Fra-2, a novel target in liver fibrosis

Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne

Lipoprotein subfractions

Lipoprotein metabolism

Lipoprotein metabolism

Lipoprotein(a)

Lipoprotein (a)

Antisense and ribozyme methodology

Antisense research and application

Antisense and ribozyme methodology

Lipoprotein und apolipoprotein abnormalities in children undergoing maintenance hemodialysis therapy

Postmenopausal Hormone Replacement Therapy with Tibolone Decreases Serum Lipoprotein(a)

Antisense oligonucleotide-based therapy against Fra-2, a novel target in liver fibrosis

Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne

Lipoprotein subfractions

Lipoprotein metabolism

Lipoprotein metabolism

Lipoprotein(a)

Lipoprotein (a)

Antisense and ribozyme methodology

Antisense research and application

Antisense and ribozyme methodology

Lipoprotein und apolipoprotein abnormalities in children undergoing maintenance hemodialysis therapy

Postmenopausal Hormone Replacement Therapy with Tibolone Decreases Serum Lipoprotein(a)

Antisense oligonucleotide-based therapy against Fra-2, a novel target in liver fibrosis

Evaluation of serum MMP-9 as predictive biomarker for antisense therapy in Duchenne

Lipoprotein subfractions

Lipoprotein metabolism

Lipoprotein metabolism

Lipoprotein(a)

Lipoprotein (a)

Related objects

Reset password